Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluate Established Anti-DEFA5 mAbs Diagnostic Efficacy and Safety in IBD

NCT05663671 is registered in ClinicalTrials.gov with Meharry Medical College as lead sponsor.

NCT NCT05663671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05663671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluate Established Anti-DEFA5 mAbs Diagnostic Efficacy and Safety in IBD
Lead sponsor
Meharry Medical College
Phase
Observational
Overall status
Unknown status
Start date
June 1, 2023
Completion date
June 30, 2025
Enrollment
230 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn colitis, indeterminate colitis, inflammatory bowel diseases, ulcerative colitis